From October 1 2026, tacrolimus 0.1% ointment will be available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of atopic dermatitis. Eligible patients must be at least 16 years of age and have…
Read more
The Australian Commission on Safety and Quality in Health Care recently released the 2026 National Model for Clinical Governance, providing updated guidance on clinical governance to help health services deliver consistently high-quality care. The…
Read more
From 1 September 2026, the Pharmaceutical Benefits Scheme (PBS) listing for pembrolizumab was significantly expanded with the addition of a multi-cancer listing. The new listing provides subsidised access for patients with immunotherapy sensitive advanced…
Read more
HPS Pharmacies wish to advise that Omegapharm is experiencing a supply interruption for mitomycin vials as follows: Mitomycin Omegapharm Mitomycin 20mg ARTG 243554 This supply interruption is related to a quality discrepancy identified in…
Read more
A missed or delayed dose of time critical medicines can cause harm to the patient or compromise the therapeutic effect, resulting in suboptimal therapy. Knowledge of the half-life of a medication helps in identifying…
Read more
HPS Pharmacies wish to advise that Pfizer is anticipating a supply interruption for diazepam ampoules as follows: DBL™ Diazepam Ampoules Diazepam 10mg/2ml ARTG 115049 This supply interruption is expected to occur between late September…
Read moreTopical Tacrolimus Added to the PBS (Sep. 25 2026)
National Model for Clinical Governance (Sep. 18 2026)
Expansion of PBS Listing for Pembrolizumab (Sep. 11 2026)
Availability of Mitomycin Omegapharm 20mg (Sep. 08 2026)
Missed Medication Doses (Sep. 04 2026)
Availability of DBL™ Diazepam Ampoules (Sep. 02 2026)
Availability of DBL™ Promethazine Hydrochloride Ampoules (Sep. 01 2026)
New PBS-Listed Option for Severe Osteoporosis: Abaloparatide (Aug. 28 2026)
Availability of Fresofol® (Aug. 26 2026)
Drug Recall for Movicol® (Aug. 24 2026)
Drug Recall for Medicianz Mupirocin Ointment (Aug. 21 2026)
Chronic insomnia management using non-pharmacological practices (Aug. 21 2026)
Availability of Salbutamol Nebules (Aug. 19 2026)
Drug Recall for Eribulin Dr. Reddy’s 1 mg/2 mL vials (Aug. 17 2026)
New Therapy for Low-Grade Glioma (Aug. 14 2026)
Pneumococcal vaccine update (Aug. 07 2026)
GLP-1 Analogues: New Warning for Rare Vision Disorder (Jul. 31 2026)
Aseptic Preparation of Medicinal Products in Health Establishments – Overview of PIC/S PE 010-4 Annex 1 (Part 2) (Jul. 24 2026)
Discontinuation of Phenytoin Ampoules 100mg/2mL (Jul. 23 2026)
New Therapy for Myasthenia Gravis (Jul. 17 2026)
Availability of Phenobarbitone 200 mg Ampoules (Jul. 16 2026)
Discontinuation of Epilim® Crushable Tablets (Jul. 10 2026)
Aseptic Preparation of Medicinal Products in Health Establishments – Overview of PIC/S PE 010-4 Core Chapters (Part 1) (Jul. 10 2026)
Long-Acting Insulin on the PBS (Jul. 03 2026)
Discontinuation of Sublocade® (Jul. 02 2026)
Availability of DBL™ Promethazine Hydrochloride Ampoules (Jun. 30 2026)
Availability of Ketamine Interpharma Ampoules (Jun. 29 2026)
An Overview of Hordeolum (Stye): Causes, Classification, Presentation and Treatment Strategies (Jun. 26 2026)
Availability of Holoxan® Vials (Jun. 24 2026)
Availability of Marcain® 0.5% 20mL Ampoules (Jun. 24 2026)
PBS Criteria Expanded for Acalabrutinib (Jun. 19 2026)
Availability of Salbutamol Nebules (Jun. 17 2026)
Discontinuation of Gastrografin® and Urografin® 30% (Jun. 16 2026)
Pityriasis Lichenoides (Jun. 12 2026)
Paxlovid® in Renal Impairment (Jun. 05 2026)
An Overview of Chronic Kidney Disease (May. 29 2026)
Drug Recall for Cipla Hydrocortisone Vials (May. 25 2026)
Fruquintinib on the PBS (May. 22 2026)
Availability of Prostin® E2 (May. 19 2026)
Dyshidrotic Eczema (May. 15 2026)
New Indication for Semaglutide (May. 08 2026)
Availability of Nitrostat® Sublingual Tablets (May. 07 2026)
Availability of Isoniazid 100mg (May. 04 2026)
Discontinuation of Zoladex® 3.6mg Implant (May. 01 2026)
Psychotropic Medicines and Metabolic Monitoring (May. 01 2026)
Availability of Gliclazide 80mg (Apr. 30 2026)
Dug Recall and Product Correction for Adrenaline-Link (Apr. 24 2026)
Expanded use of Durvalumab (Apr. 24 2026)
Availability of Aprepitant Capsules (Apr. 22 2026)
Product Correction for Flixotide® and Pavtide® Accuhalers (Apr. 21 2026)
Drug Recall for Cardizem® and Vasocardol® 60mg Tablets (Apr. 20 2026)
Discontinuation of Akynzeo® Vials (Apr. 17 2026)
Monoclonal Antibody Nomenclature: Understanding the Changes (Apr. 17 2026)
Availability of Xylocaine® 1% DuoFit Theatre pack 20 mL (Apr. 16 2026)
Intranasal Influenza Vaccine (Apr. 10 2026)
Dosing Considerations in Obesity (Apr. 03 2026)
Ravulizumab for Myasthenia Gravis (Mar. 27 2026)
Incident Reporting and Learning from Near Misses (Mar. 20 2026)
Product Alert for Fentanyl GH Ampoules (Mar. 13 2026)
Expanded PBS Listing for IncobotulinumtoxinA (Mar. 13 2026)
Availability of Codeine Oral Liquid (Mar. 06 2026)
Updated Safety Information: Pegylated Liposomal Doxorubicin (Mar. 06 2026)
Product Recall for Gastrografin® and Urografin® (Mar. 04 2026)
Needle-free Anaphylaxis Treatment (Feb. 27 2026)
Availability of Betahistine 16mg Tablets (Feb. 25 2026)
Infusion Reactions (Feb. 20 2026)
Product Alert for Oxycodone Sandoz 5mg Modified Release Tablets (Feb. 18 2026)
Landiolol in Acute Care Settings (Feb. 13 2026)
Abiraterone Formulations (Feb. 06 2026)
Discontinuation of Epilim® Crushable Tablets (Feb. 04 2026)
Ublituximab on the PBS (Jan. 30 2026)
Availability of Dantrium® Vials (Jan. 29 2026)
Hereditary Fructose Intolerance (Jan. 23 2026)
Availability of Palexia® IR (Jan. 22 2026)
Availability of Palexia® IR (Jan. 20 2026)
Availability of Prostin® E2 (Jan. 20 2026)
Availability of Salbutamol 5mg Nebules (Jan. 19 2026)
Discontinuation of Flamazine® Cream (Jan. 16 2026)
Discontinuation of Mivacron® Ampoules (Jan. 16 2026)
Odevixibat on the PBS (Jan. 16 2026)
Availability of Apresoline® Ampoules (Jan. 12 2026)
Availability of Tranexamic Acid Tablets (Jan. 12 2026)
Safe Use of Long-acting Antipsychotic Injections (Jan. 09 2026)
Updated Warnings for GLP-1 Agonists (Jan. 02 2026)
Drug Interactions and Smoking (Dec. 26 2025)
Product Recall for Famvir® 500mg (Dec. 24 2025)
Product Recall for Gelofusine® 500mL (Dec. 22 2025)
Subcutaneous Ocrelizumab (Dec. 19 2025)
Scheduling Changes for Vitamin B6 (Dec. 12 2025)
Availability of Pramipexole (Dec. 11 2025)
Denosumab Treatment Delays (Dec. 05 2025)
Deprescribing Clinical Practice Guideline (Nov. 28 2025)
PBS Listing Extended for Daratumumab (Nov. 21 2025)
Availability of Noradrenaline Medsurge 2 mg/2 mL Ampoules (Nov. 20 2025)
Iron Injections (Nov. 14 2025)
Availability of Tranexamic Acid Tablets (Nov. 13 2025)
PBS Expansion for Empagliflozin (Nov. 07 2025)
New Resources to Guide Sepsis Care And Support (Oct. 31 2025)
Topical Anaesthesia in Infants (Oct. 24 2025)
Availability of Rifampicin Capsules (Oct. 20 2025)
Dopamine Dysregulation Syndrome (Oct. 17 2025)
Capivasertib on the PBS (Oct. 10 2025)
Product Recall for Tracrium® 25mg/2.5mL Ampoules (Oct. 09 2025)
From Compliance to Adherence to Concordance: The Evolution from Paternalistic Medicine to Patient Empowerment (Oct. 03 2025)
Guselkumab: Expanded Indications (Sep. 26 2025)
Dementia Action Week (15th – 21st September) (Sep. 19 2025)
Expanded PBS Listing for Dupilumab (Sep. 12 2025)
Availability of Apresoline® Ampoules (Sep. 05 2025)
Updates to the Recommendations for the Prevention of Infective Endocarditis (Sep. 05 2025)
Nivolumab plus Ipilimumab Therapy (Aug. 29 2025)
Cholestatic Pruritus in Palliative Care (Aug. 22 2025)
New Treatment for Parkinson’s Disease on the PBS (Aug. 15 2025)
Paracetamol and Metabolic Acidosis (Aug. 08 2025)
Drug Recall for Palexia® SR 100mg (Aug. 05 2025)
Ivosidenib on the PBS (Aug. 01 2025)
Product Alert for Bicillin L-A 1.2 Million Units (Jul. 28 2025)
Angioedema During ACE Inhibitor Therapy (Jul. 25 2025)
Discontinuation of Twynsta® and Pritor/Amlodipine Tablets (Jul. 21 2025)
Avoiding Errors with RSV Prevention Medicines (Jul. 18 2025)
Availability of Temgesic® Sublingual Tablets (Jul. 14 2025)
Availability of Clopidogrel Tablets (Jul. 11 2025)
Reducing Hospitalisation for COVID-19 (Jul. 11 2025)
Availability of Apresoline® Ampoules (Jul. 08 2025)
Availability of Lidocaine 2% Ampoules (Jul. 07 2025)
Expanded PBS Listing for Trikafta® (Jul. 04 2025)
Availability of Tiger Snake Antivenom® (Jul. 03 2025)
Availability of Lidocaine 1% Ampoules (Jul. 03 2025)
The use of calcitonin-gene related peptide antagonists in pregnancy and lactation – a brief safety review (Jun. 27 2025)
Discontinuation of Phospho-Soda® Oral Solution (Jun. 26 2025)
Edaravone on the PBS (Jun. 20 2025)
Availability of Capecitabine 500mg Tablets (Jun. 17 2025)
Availability of Zyprexa® IM 10mg (Jun. 13 2025)
Availability of Prazosin Tablets (Jun. 13 2025)
Updated Guidelines for Acute Coronary Syndromes (Jun. 13 2025)
Constrained supply of Paracetamol Kabi 1g/100mL Vials (Jun. 12 2025)
Discontinuation of Pfizer Sodium Chloride 0.9% IV infusion (Jun. 06 2025)
Dexrazoxane for the Prevention of Cardiotoxicity (Jun. 06 2025)
Availability of Ozempic® (Jun. 04 2025)
Discontinuation of Saxenda® (Jun. 02 2025)
Reducing Falls in Older Adults (May. 30 2025)
Longer-acting Aripiprazole on the PBS (May. 23 2025)
SGLT-2 Inhibitors – Beyond Diabetes (May. 16 2025)
Esketamine Nasal Spray (May. 09 2025)
Discontinuation of Durogesic® Patches (May. 02 2025)
Hypokalaemia (May. 02 2025)
Influenza Vaccination for the 2025 Season (Apr. 25 2025)
Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia (Apr. 18 2025)
Empirical Antibiotic Treatment of Acute Cystitis (Apr. 11 2025)
Availability of Bicillin® L-A 1.2 Million Units (Apr. 08 2025)
Aetiology, risk factors and management of vulvovaginal candidiasis (Apr. 04 2025)
Discontinuation of Naropin® with Fentanyl Injection Bags (Mar. 31 2025)
Endometriosis Therapy to be Added to the PBS (Mar. 28 2025)
Availability of Amiodarone Ampoules (Mar. 24 2025)
Fluoroquinolone Adverse Reactions (Mar. 20 2025)
Availability of Azithromycin 500mg Tablets (Mar. 17 2025)
Availability of Amiodarone Ampoules (Mar. 17 2025)
Osilodrostat on the PBS (Mar. 14 2025)
Availability of Midazolam Viatris 5mg/1mL (Mar. 12 2025)
Availability of Xylocaine® 1% Ampoules (Mar. 07 2025)
Buruli Ulcer (Mar. 07 2025)
Metronidazole Update (Feb. 28 2025)
Availability of Heparin (Feb. 27 2025)
Reporting Adverse Events (Feb. 21 2025)
Availability of Xylocaine® 1% Ampoules (2mL) (Feb. 17 2025)
Selpercatinib on the PBS (Feb. 14 2025)
Discontinuation of Nicorette® Inhalator (Feb. 12 2025)
Availability of Amiodarone Ampoules (Feb. 10 2025)
Pharmacogenomics (Feb. 07 2025)
Montelukast Safety Update (Jan. 31 2025)
Discontinuation of Multiple Insulin Products (Jan. 30 2025)
National Standard for Chronic Obstructive Pulmonary Disease (Jan. 24 2025)
Availability of Gentamicin and Tobramycin Injection (Jan. 23 2025)
Packaging Update for Adrenaline Aguettant 1:10,000 (Jan. 21 2025)
Drug Quarantine for Cipla Hydrocortisone 100mg Vials (Jan. 21 2025)
Long-acting Risperidone (Jan. 17 2025)
Urinary Tract Infections and Diabetes Mellitus (Jan. 10 2025)
Availability of Mytolac® 90mg (Jan. 08 2025)
Combination Product for Type 2 Diabetes (Jan. 03 2025)
Antiemetics (Dec. 27 2024)
Drug Recall for Baxter Sodium Chloride 2.25g/250mL (Dec. 24 2024)
Availability of Midazolam Viatris 5mg/5mL (Dec. 20 2024)
Expanded PBS Criteria for Dapagliflozin (Dec. 20 2024)
Discontinuation of Protaphane® InnoLet® (Dec. 16 2024)
Upcoming Changes to Paracetamol Scheduling (Dec. 13 2024)
Availability of Morphine Juno 50mg Ampoules (Dec. 12 2024)
Dienogest on the PBS (Dec. 06 2024)
Availability of DBL Acetylcysteine Injection (Dec. 05 2024)
Availability of Oxynorm® Liquid (Dec. 03 2024)
Availability of Methylphenidate Modified-Release Tablets (Nov. 29 2024)
Dementia Literacy (Nov. 29 2024)
Availability of Bicillin® L-A 1.2 Million Units (Nov. 25 2024)
Promethazine Safety Update (Nov. 22 2024)
Availability of Tambocor® Ampoules (Nov. 21 2024)
Availability of Nizatidine and Famotidine (Nov. 21 2024)
Allergies and Antimicrobial Resistance (Nov. 15 2024)
Availability of Heparin (Nov. 13 2024)
Drug Recall for Metformin Sandoz 500mg (Nov. 12 2024)
Availability of Adrenaline-Link 1:1,000 Ampoules (Nov. 11 2024)
Romosozumab as a First-Line Therapy (Nov. 08 2024)
Availability of Paxam® 2mg (Nov. 07 2024)
Drug Recall for Salofalk® Enemas (Nov. 04 2024)
Respiratory Syncytial Virus (Nov. 01 2024)
Product Defect Alert for Adrenaline-Link 1:10,000 (Oct. 28 2024)
Availability of Heparin 5,000IU/1mL (Oct. 25 2024)
Diltiazem and Direct Oral Anticoagulants (Oct. 25 2024)
Product Availability and Safety Notice for Adrenaline (Oct. 23 2024)
Packaging Update for Hydromorphone Juno (Oct. 21 2024)
Antibiotic-Associated Diarrhoea (Oct. 18 2024)
2025 HPS Lecture Series Programme (Oct. 11 2024)
Icosapent Ethyl for the Prevention of Cardiovascular Events (Oct. 11 2024)
Availability of Heparin 25,000IU/5mL (Oct. 10 2024)
Availability of Ezetimibe Tablets (Oct. 04 2024)
Product Defect Correction Compounded Parenteral Nutrition and IV Solutions (Oct. 04 2024)
Medicines and Breastfeeding (Oct. 04 2024)
Availability of Bisalax® Enema (Oct. 01 2024)
Expanded PBS Listing for Cabozantinib (Sep. 27 2024)
Device Recall for Refresh® Night Time Eye Ointment (2 x 3.5g) (Sep. 25 2024)
Availability of Urografin® (Sep. 23 2024)
Availability of Atropine Sulfate Ampoules (Sep. 20 2024)
Safe Use of High-Risk Medications (Sep. 20 2024)
Discontinuation of Mixtard® 30/70 and Fiasp® (Sep. 19 2024)
Availability of Heparinised Saline (Sep. 13 2024)
Expanded PBS Listing for Trastuzumab Deruxtecan (Sep. 13 2024)
Availability of Heparin 5,000IU/5mL (Sep. 12 2024)
Availability of Cosopt®, Timoptol®, Timoptol®-XE Eye Drops (Sep. 11 2024)
Benzyl Alcohol in Pharmaceutical Products (Sep. 06 2024)
Azithromycin Safety Update (Aug. 30 2024)
Semaglutide for Weight Management (Aug. 23 2024)
Drug Recall for Palexia® SR 50mg (Aug. 21 2024)
Drug Recall for Folic Acid Injectables (Aug. 16 2024)
Oromucosal Midazolam (Aug. 16 2024)
Discontinuation of Xylocaine 0.5% With Adrenaline 1:200,000 (Aug. 14 2024)
Availability of IV Fluids Update (Aug. 12 2024)
Medication-Induced Taste Disorders (Aug. 09 2024)
Packaging Update for Metoprolol IV Viatris 5mg/5mL (Aug. 07 2024)
Daunorubicin and Cytarabine Combination Product (Aug. 02 2024)
Respiratory Syncytial Virus (Jul. 26 2024)
Availability of Intravenous Fluids (Jul. 24 2024)
Anifrolumab Added to the PBS (Jul. 19 2024)
Discontinuation of Symbicort® Rapihaler™ 50/3 (Jul. 17 2024)
Availability of Ozempic® (Jul. 17 2024)
Discontinuation of Timoptol® and Timoptol®-XE Eye Drops (Jul. 17 2024)
Safety Notice – Adrenaline Aguettant 1:10,000 (1 mg / 10 mL) PFS (Jul. 17 2024)
Discontinuation of Depo-Provera® and Depo-Ralovera® Vials (Jul. 15 2024)
Availability of Gentamicin Ampoules (Jul. 11 2024)
Medicine Safety Alert for Andrographis – Anaphylaxis Risk (Jul. 10 2024)
Drug Recall for Aciclovir ACCORD 500 mg/ 20mL injection vials (Jul. 05 2024)
Overview of cephalosporins (Jul. 05 2024)
Availability of Morphine Oral Solution (Jun. 28 2024)
Availability of OxyNorm® (Jun. 28 2024)
Novel Therapy for Acne (Jun. 28 2024)
Availability of Wafermine™ Update (Jun. 27 2024)
Iron Infusions (Jun. 21 2024)
Availability of Wafermine™ (Jun. 17 2024)
Extended PBS Listing for Secukinumab (Jun. 14 2024)
Availability of Clexane® 40mg (Jun. 13 2024)
Defect Correction for Sublimaze® Injection (Jun. 07 2024)
Sulfites in Pharmaceutical Products (Jun. 07 2024)
Availability of Gentamicin Ampoules (Jun. 05 2024)
Recall for Levomepromazin-Neuraxpharm Ampoules (May. 31 2024)
Safety Update for SSRI and SNRI Medicines (May. 31 2024)
Availability of Cisplatin (May. 30 2024)
Availability of Epirubicin (May. 30 2024)
Packaging Update for Medsurge Hydromorphone 2 mg/1 mL (May. 29 2024)
Availability of Solu-Cortef® Act-O-Vial (May. 27 2024)
Potentially Inappropriate Medicines in the Australian Setting (May. 24 2024)
Availability of Clexane® 60mg (May. 20 2024)
Tafamidis on the PBS (May. 17 2024)
Discontinuation of Oruvail® SR and Orudis® SR (May. 10 2024)
Intranasal Corticosteroids in Allergic Rhinitis (May. 10 2024)
Availability of Orencia® (May. 09 2024)
Availability of Octreotide Ampoules (May. 03 2024)
Novel Therapy for Hypertrophic Cardiomyopathy (May. 03 2024)
Defect Correction and Recall Update for Panadol® Children 100mg/mL (May. 01 2024)
Defect Correction for Ryaltris® Nasal Spray (Apr. 30 2024)
Defect Correction for Panadol® Children 100mg/mL (Apr. 29 2024)
Availability of Orencia® (Apr. 29 2024)
Updated COVID-19 Vaccine Recommendations (Apr. 26 2024)
Discontinuation of Lasix® 40mg Ampoules (Apr. 23 2024)
Discontinuation of Tracleer® Tablets (Apr. 23 2024)
New Medication for Hot Flushes (Apr. 19 2024)
Discontinuation of Voltaren® Eye Drops and Suppositories (Apr. 17 2024)
Medication-Overuse Headache (Apr. 12 2024)
Drug Recall for K-Citra 10 Tablets (Apr. 09 2024)
Inclisiran on the PBS (Apr. 05 2024)
Availability of Local Anaesthetic Products (Apr. 04 2024)
Availability of Fresofol® 1% MCT/LCT (Apr. 04 2024)
PBS Subsidies for Morphine Oral Solution (Apr. 03 2024)
Data and Decisions for the Three Different CDK4/6 Inhibitors (Mar. 29 2024)
Availability of Trimethoprim (Mar. 27 2024)
Availability of Heparin 5,000IU/5mL (Mar. 26 2024)
Discontinuation of Metalyse® 40mg (Mar. 25 2024)
Expanded PBS Listing for Dapagliflozin (Mar. 22 2024)
Changes Affecting Submissions for Unapproved Therapeutic Goods (Mar. 15 2024)
Cephalosporin-induced Neurotoxicity (Mar. 08 2024)
Pneumoccoccal Vaccines (Mar. 01 2024)
Availability of Gliclazide (Feb. 29 2024)
Availability of Morphine Oral Solution (Feb. 29 2024)
Tebentafusp for Uveal Melanoma (Feb. 23 2024)
Defect Correction for ADT™ Booster (Feb. 21 2024)
Potential Anaesthesia Risk with GLP-1 Agonists (Feb. 16 2024)
Availability of Local Anaesthetic Products (Feb. 15 2024)
Availability of DBL™ Magnesium Sulfate (Feb. 15 2024)
Discontinuation of Vivaxim® Injection (Feb. 14 2024)
Availability of Parenteral Paracetamol (Feb. 13 2024)
Subcutaneous Natalizumab on the PBS (Feb. 09 2024)
Mycobacterium bovis BCG for Bladder Cancer (Feb. 02 2024)
Discontinuation of DBL™ Hyoscine Hydrobromide Ampoules (Feb. 01 2024)
Availability of Bicillin® L-A (Feb. 01 2024)
Defect Correction for Spiriva® Respimat® (Jan. 31 2024)
COVID therapies and the National Medication Stockpile (Victoria) (Jan. 31 2024)
Availability of BCG Bladder Instillation (Jan. 31 2024)
Melanoma Therapy Added to the PBS (Jan. 26 2024)
Insulin Cartridge Defect Alert (Jan. 22 2024)
Drug Recall for Metformin Sandoz 1000mg (Jan. 22 2024)
Patient Deterioration in the Healthcare Setting (Jan. 19 2024)
Service Update for ClopineCENTRAL® (Jan. 17 2024)
Discontinuation of Imigran® Nasal Spray and Injection® (Jan. 12 2024)
Expanded PBS Listing for Orkambi® (Jan. 12 2024)
Comparison of different types of G-CSF (Jan. 05 2024)
Medications for the Management of Urinary Incontinence (Dec. 22 2023)
Availability of Xylocaine with Adrenaline (Dec. 21 2023)
Enfortumab Vedotin on the PBS (Dec. 15 2023)
Update on InterPharma Sodium Chloride 0.9% ampoules (Dec. 15 2023)
Oral Therapies in Metastatic Prostate Cancer (Dec. 08 2023)
Drug Recall for InterPharma Sodium Chloride 0.9% 30mL (Dec. 01 2023)
Reversing the Anticoagulant Effects of Factor Xa Inhibitors (Dec. 01 2023)
Drug Quarantine Update for InterPharma Sodium Chloride 0.9% (Nov. 28 2023)
Drug Quarantine for InterPharma Sodium Chloride 0.9% (Nov. 24 2023)
Antifungal Resistance (Nov. 24 2023)
Trastuzumab Deruxtecan on the PBS (Nov. 17 2023)
Drug Recall for Lisinopril Sandoz (Nov. 13 2023)
Evidence-based Non-drug Treatments in Dementia – Reminiscence Therapy (Nov. 10 2023)
Baclofen Safety Update (Nov. 03 2023)
Discontinuation of OxyNorm®, MS Mono® and Sevredol® (Nov. 01 2023)
Drug Recall for Dasatinib Dr.Reddy’s (Oct. 27 2023)
An Overview of Fungi (Oct. 27 2023)
Packaging Update for Baxter Compounded IV Bags (Oct. 23 2023)
Oral Azacitidine on the PBS (Oct. 20 2023)
Packaging Update for Potassium Chloride 22.3% Concentrated Injection (Oct. 17 2023)
Recall of Sodium Chloride 0.9% Freeflex 100mL injection bag (Oct. 13 2023)
Lower Urinary Tract Symptoms in Men (Oct. 13 2023)
2024 HPS Lecture Series Programme (Oct. 09 2023)
Enzalutamide for Metastatic Hormone-Sensitive Prostate Cancer (Oct. 06 2023)
Weight Loss Medications (Sep. 29 2023)
Defect Correction for Midazolam Alphapharm (Sep. 26 2023)
Darolutamide and Liver Test Abnormalities (Sep. 22 2023)
Revised Hip Fracture Clinical Care Standard (Sep. 15 2023)
Patiromer on the Pharmaceutical Benefits Scheme (Sep. 08 2023)
Availability of Morphine Oral Solution (Sep. 01 2023)
Antibiotic Use in the Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (Sep. 01 2023)
Curcumin and Liver Injury (Aug. 25 2023)
Erythropoietin Resistance (Aug. 18 2023)
Eptinezumab on the Pharmaceutical Benefits Scheme (Aug. 11 2023)
Amiodarone-induced Thyroid Disorders (Aug. 04 2023)
Availability of Mirena® (Aug. 01 2023)
Baricitinib for Alopecia Areata (Jul. 28 2023)
Availability of Lidocaine Ampoules (Jul. 27 2023)
Availability of Nizatidine (Jul. 26 2023)
Drug Recall for Sabril® (Jul. 21 2023)
Biological Therapies for Rheumatoid Arthritis (Jul. 21 2023)
A Comparison of Acalabrutinib Tablets and Capsules (Jul. 14 2023)
Mineralocorticoid Receptor Antagonists (Jul. 07 2023)
Migraine Prophylaxis and Pregnancy (Jun. 30 2023)
Neo-Adjuvant Treatment of Melanoma and Directed Therapy from the PRADO Trial (Jun. 23 2023)
Pembrolizumab and Lenvatinib for Endometrial Cancer (Jun. 16 2023)
Discontinuation of Ordine® Oral Solution (Jun. 15 2023)
Anticoagulant-Related Nephropathy (Jun. 09 2023)
Discontinuation of Ordine® Oral Solution (Jun. 07 2023)
Discontinuation of Capoten® Oral Liquid (Jun. 05 2023)
Availability of Septrin® Oral Liquid (Jun. 05 2023)
Discontinuation of Diazepam Rectal Solution (Jun. 05 2023)
Apalutamide on the PBS (Jun. 02 2023)
Availability of Vasodrine® Tablets (May. 26 2023)
Sepsis (May. 26 2023)
Availability of Local Anaesthetic Products (May. 25 2023)
Availability of Edronax® (May. 25 2023)
Availability of Dostinex® (May. 25 2023)
Availability of Synarel® (May. 25 2023)
Availability of Heparin 5,000IU/5mL (May. 24 2023)
Availability of Heparinised Saline (May. 24 2023)
New Boxed Warnings for JAK Inhibitors (May. 19 2023)
Availability of Actilyse® (May. 15 2023)
Availability of Nizatidine (May. 15 2023)
Patient Self-Management (May. 12 2023)
Product Defect Correction – Water for Injection ampoules co-packed with Simulect® (May. 08 2023)
New Abiraterone Formulation (May. 05 2023)
Availability of Pfizer Potassium Chloride Ampoules (May. 04 2023)
Availability of Souvenaid® (May. 02 2023)
Availability of Cefaclor (May. 02 2023)
Availability of Lanoxin® Ampoules (Apr. 28 2023)
The Role of the Pharmacist in Survivorship Care (Apr. 28 2023)
Availability of Somac® Granules (Apr. 26 2023)
Availability of Glaumox® Vials (Apr. 26 2023)
Availability of Bromhexine Oral Liquid (Apr. 26 2023)
Seasonal Influenza Vaccines for 2023 (Apr. 21 2023)
Recurrent Urinary Tract Infections in Women (Apr. 14 2023)
Availability of Suxamethonium Juno (Apr. 12 2023)
Availability of Local Anaesthetic Products (Apr. 12 2023)
Ruxolitinib for Graft-Versus-Host Disease (Apr. 07 2023)
Enerzair® Breezhaler® (Mar. 31 2023)
Availability of Synarel® Nasal Spray (Mar. 30 2023)
Update on Pregabalin During Pregnancy (Mar. 24 2023)
Availability of Warfarin (Mar. 20 2023)
Tirzepatide: a New Treatment for Type 2 Diabetes and Weight Loss (Mar. 17 2023)
Removal of Iopidine® Eye Drops from PBS (Mar. 10 2023)
Availability of Coumadin® (Mar. 10 2023)
Updated Contraindications for Paxlovid™ (Mar. 10 2023)
Availability of Celestone® Chronodose® Injection Ampoule (Mar. 07 2023)
Vedolizumab and Ustekinumab for the Treatment of Crohn’s Disease (Mar. 03 2023)
Updated Packaging for Coumadin® and Marevan® (Mar. 01 2023)
Availability of Fentanyl Intranasal (Mar. 01 2023)
Availability of Local Anaesthetic Products (Mar. 01 2023)
Recall of Pholcodine-Containing Products (Mar. 01 2023)
Updated HPV Vaccine Dosing Schedule (Feb. 24 2023)
Discontinuation of Phebra Folic Acid Vials (Feb. 23 2023)
Availability of Diazepam Rectal Solution (Feb. 21 2023)
Availability of Teicoplanin (Feb. 17 2023)
Availability of Celestone® Chronodose® Injection Ampoule (Feb. 17 2023)
Availability of Cefuroxime (Feb. 17 2023)
Wernicke-Korsakoff Syndrome (Feb. 17 2023)
Recall of Celestone® Chronodose® Injection Ampoule (Feb. 15 2023)
Discontinuation of Riodine® S Surgical Scrub (Feb. 13 2023)
Opicapone for Parkinson’s Disease (Feb. 10 2023)
Availability of Temgesic® Sublingual Tablets (Feb. 09 2023)
Discontinuation of Cabazitaxel 60mg/1.5mL (Feb. 07 2023)
Gestational Diabetes (Feb. 03 2023)
Availability of Fluconazole-Baxter Vials (Feb. 02 2023)
Availability of Difflam® Solution (Feb. 01 2023)
Removal of Androderm® from PBS (Jan. 31 2023)
Discontinuation of Byetta® (Jan. 31 2023)
Acute Respiratory Toxicity and Hydrochlorothiazide (Jan. 27 2023)
Product Defect Alert for Vancomycin Viatris Vials (Jan. 24 2023)
Availability of Fentanyl Intranasal (Jan. 20 2023)
Glucagon-like Peptide-1 Receptor Agonists (Jan. 20 2023)
Product Defect Alert – Veletri® Consumables Kit (Jan. 13 2023)
Faricimab on the PBS (Jan. 13 2023)
Availability of Antibiotics (Jan. 11 2023)
The Clinical Merits Associated with Utilising a Prescribing Pharmacist (Jan. 06 2023)
Pegcetacoplan on the PBS (Dec. 30 2022)
Recall of Pharmacy Action Dry Cough Relief (Dec. 29 2022)
Recall of Medsurge Mupirocin Nasal Ointment (Dec. 29 2022)
Defect Alert for CADD™ Infusion System Disposables (Dec. 23 2022)
Availability of Imdur® and Monodur® (Dec. 23 2022)
Availability of Cefalexin Suspension (Dec. 23 2022)
Improving Medication Use at Transitions of Care (Dec. 23 2022)
Availability of Mestinon® (Dec. 19 2022)
Recall of Quinapril (Dec. 19 2022)
New Formulation of Lorazepam (Dec. 16 2022)
Availability of Trimethoprim (Dec. 14 2022)
Vericiguat for Heart Failure (Dec. 09 2022)
PBAC Recommendations for COVID-19 Oral Antivirals (Dec. 02 2022)
Availability of Trulicity® (Dec. 01 2022)
Availability of Ozempic® (Dec. 01 2022)
Availability of Amoxicillin + Clavulanic Acid (Nov. 25 2022)
Probiotics for Preterm Infants (Nov. 25 2022)
Discontinuation of Chirocaine® (Nov. 22 2022)
Extended PBS Listing for Cemiplimab (Nov. 18 2022)
Removal of Rebif® from PBS (Nov. 17 2022)
Discontinuation of Otrivin® Nasal Drops (Nov. 17 2022)
Availability of Phenobarbital Elixir (Nov. 14 2022)
Discontinuation of Jurnista® (Nov. 14 2022)
Availability of Riodine® (Nov. 11 2022)
Updated Recommendations for the Dosing of Anticancer Drugs in Kidney Dysfunction (Nov. 11 2022)
Availability of Amoxicillin (Nov. 09 2022)
Drug Recall for DBL™ Vancomycin 500mg Vials (Nov. 09 2022)
Vitamin B6 Supplements and Peripheral Neuropathy (Nov. 04 2022)
Defect Correction for Minisart® Filters (Nov. 03 2022)
Removal of temporary tocilizumab PBS listings (Nov. 03 2022)
Solid Oral Dose Forms and Swallowing Difficulties (Oct. 28 2022)
Discontinuation of Chlorhexidine 0.2% Catheter Prep Ampoule (Oct. 25 2022)
Decitabine With Cedazuridine (Inqovi®) (Oct. 21 2022)
Vancomycin Use in Arthroplasty Patients (Oct. 14 2022)
2023 HPS Lecture Series Programme (Oct. 13 2022)
Availability of Metalyse® (Oct. 13 2022)
Availability of Metronidazole (Oct. 12 2022)
Availability of Ilevro® Eye Drops (Oct. 12 2022)
Expanded PBS Listing for Pembrolizumab (Oct. 07 2022)
Availability of Vancomycin Vials (Oct. 06 2022)
Drug Holidays from Bisphosphonates (Sep. 30 2022)
Niraparib on the PBS (Sep. 23 2022)
Iron Deficiency Anaemia (Sep. 16 2022)
Availability of Amoxicillin + Clavulanic Acid 875/125mg (Sep. 14 2022)
Availability of Amoxicillin 250mg/5mL (Sep. 14 2022)
Expanded PBS Listing for Dapagliflozin (Sep. 09 2022)
Product Alert for Trikafta® (Sep. 06 2022)
Drug-induced QT Interval Prolongation (Sep. 02 2022)
Availability of Atracurium (Aug. 31 2022)
Availability of Metronidazole Tablets (Aug. 30 2022)
New PBS Therapy for Multiple Sclerosis (Aug. 26 2022)
Availability of Amoxicillin + Clavulanic Acid 875/125mg (Aug. 23 2022)
Monkeypox in Australia (Aug. 19 2022)
Longer Acting Paliperidone (Aug. 12 2022)
Availability of Trulicity® (Aug. 11 2022)
Availability of Ozempic® (Aug. 11 2022)
Anticholinergic Burden (Aug. 05 2022)
Availability of Pulmicort® Turbuhaler® (Aug. 03 2022)
Packaging alert for Xylocaine® 2% with Adrenaline (Aug. 02 2022)
Availability of Cetrotide® (Jul. 29 2022)
New Therapy for Systemic Lupus Erythematosus (Jul. 29 2022)
Availability of Vecure® (Jul. 27 2022)
Availability of Morphine Juno 50mg Ampoules (Jul. 26 2022)
Should I take the full course of antibiotics? (Jul. 22 2022)
Availability of BenPen™ (Jul. 19 2022)
Availability of Chlorsig® Ointment (Jul. 19 2022)
Availability Of Metronidazole Tablets (Jul. 18 2022)
Indication Extension for Lenvatinib (Jul. 15 2022)
Availability Of Ropivacaine Kabi 0.2% (Jul. 08 2022)
Availability of Metaraminol GH Pharma 3mg/6mL (Jul. 08 2022)
Considering the use of VTE prophylaxis in palliative care patients approaching or in the terminal phase (Jul. 08 2022)
Sepsis Clinical Care Standard (Jul. 01 2022)
Availability of Metalyse® (Jun. 27 2022)
Labelling Change for Calcium Gluconate Injection (Jun. 24 2022)
Availability of Mivacron® (Jun. 17 2022)
Clarithromycin and Electrolyte Disturbances (Jun. 17 2022)
Availability of Targin® (Jun. 16 2022)
Availability of Fresofol® 1% MCT/LCT (Jun. 16 2022)
Availability of Atracurium (Jun. 10 2022)
Availability of Modified-Release Oxycodone (Jun. 10 2022)
Clozapine Safety Advisory (Jun. 03 2022)
Availability of Ozempic® (Jun. 02 2022)
Prediction of Severe Neutropenia and Diarrhoea in Breast Cancer Patients Treated with Abemaciclib (May. 27 2022)
Availability of Targin® (May. 20 2022)
Triple-Negative Breast Cancer Treatment (May. 20 2022)
Availability of ‘Marcain 0.5% with Adrenaline’ (May. 18 2022)
Opioid Analgesic Stewardship in Acute Pain (May. 12 2022)
Defect Alert for Fentanyl GH 100mcg/2mL (May. 11 2022)
Availability of Elastomeric Device LV-10 (May. 06 2022)
PBS Listing Expanded for Nintedanib (May. 06 2022)
Availability of Xylocaine 0.5% with Adrenaline (May. 03 2022)
Availability of ‘Xylocaine with Adrenaline’ and ‘Marcain with Adrenaline’ (May. 03 2022)
New Therapy for Cystic Fibrosis (Apr. 29 2022)
Drug Recall for DBL™ Vancomycin (Apr. 27 2022)
Oral COVID-19 Treatment on PBS (Apr. 22 2022)
Availability of Targin® (Apr. 14 2022)
Seasonal Influenza Vaccination (Apr. 14 2022)
Availability of Oxycodone Modified-Release Tablets (Apr. 12 2022)
Packaging change for Sodium Chloride 0.9% Injection (Apr. 11 2022)
Triple-therapy Inhaler on the PBS (Apr. 08 2022)
Availability of Povidone-Iodine Solution Ampoules (Apr. 07 2022)
Availability of Dexamethasone 4mg/1mL Vials (Apr. 07 2022)
Availability of Miochol-E® (Apr. 05 2022)
Paroxysmal Nocturnal Haemoglobinuria (Apr. 01 2022)
Gemtuzumab ozogamicin on the PBS (Mar. 25 2022)
Discontinuation of Calmoseptine® Ointment (Mar. 23 2022)
Availability of Urokinase (Mar. 21 2022)
Availability of Targin® (Mar. 18 2022)
Product Notice for Zavicefta® Injection (Mar. 18 2022)
Aged Care and Chemical Restraint (Mar. 18 2022)
Cardiovascular Warnings for Donepezil (Mar. 11 2022)
Availability of Ephedrine Sulfate (Mar. 04 2022)
Availability of Clopine® Suspension (Mar. 04 2022)
Molnupiravir for COVID-19 (Mar. 04 2022)
Labelling Change for Sodium Bicarbonate 8.4% Injection (Mar. 01 2022)
Labelling Change for Magnesium Sulfate Heptahydrate 50% (Feb. 25 2022)
Levothyroxine Formulations (Feb. 25 2022)
SGLT2 Inhibitors for Heart Failure (Feb. 18 2022)
2022 HPS Lecture Series Programme (Feb. 15 2022)
Upadacitinib for Atopic Dermatitis (Feb. 11 2022)
Availability of Orencia® Syringes and Autoinjector (Feb. 11 2022)
COVID-19 Treatment Options (Feb. 04 2022)
Availability of OncoTICE® (Feb. 02 2022)
Availability of Dilaudid® Tablets (Feb. 01 2022)
Availability of Temgesic® (Jan. 24 2022)
What is Cancer Survivorship Care? (Jan. 21 2022)
Encorafenib for Colorectal Caner (Jan. 21 2022)
Availability of Fleet® (Jan. 21 2022)
Discontinuation of Lucrin® 5mg/mL Vials (Jan. 21 2022)
Availability of Solprin® (Jan. 14 2022)
Availability of Prasugrel (Jan. 14 2022)
Discontinuation of CoPlavix® (Jan. 12 2022)
Labelling Change for Calcium Gluconate Injection (Jan. 11 2022)
Safety Advisory for Pentosan Polysulfate Sodium (Jan. 07 2022)
Managing the Side Effects of Chemotherapy (Dec. 31 2021)
Update on Ceftriaxone (Dec. 21 2021)
Labelling Change for Calcium Gluconate Injection (Dec. 21 2021)
COVID-19 Vaccine Boosters (Dec. 17 2021)
Expanded PBS Listing for Venetoclax (Dec. 10 2021)
Glucagon-like Peptide-1 Analogues (Dec. 03 2021)
Availability of Local Anaesthetic Products (Dec. 03 2021)
Discontinuation of Rulide® D (Dec. 03 2021)
Availability of Elastomeric Devices (Nov. 29 2021)
Product Information Update for Glyceryl Trinitrate Wockhardt (Nov. 29 2021)
Availability of Local Anaesthetic Products (Nov. 29 2021)
Subcutaneous Daratumumab (Nov. 29 2021)
Formulation Change for Ibrance® (Nov. 29 2021)
Antimicrobial Awareness Week (Nov. 18 2021)
Triple Therapy Inhaler on the PBS (Nov. 12 2021)
Discontinuation of Citracal® (Nov. 09 2021)
Product Defect Alert for Novo Nordisk Insulins (Nov. 09 2021)
Restless Legs Syndrome (Nov. 05 2021)
Ofatumumab on the PBS (Oct. 28 2021)
Availability of Caldolor® (Oct. 28 2021)
Availability of Heparin (Oct. 27 2021)
Medication Interactions with Food (Oct. 21 2021)
Availability of Emend® IV (Oct. 19 2021)
Availability of Span-K® (Oct. 15 2021)
Ciclosporin Eye Drops (Oct. 14 2021)
Availability of Acetylcysteine Ampoules (Oct. 08 2021)
Revised Delirium Clinical Care Standard (Oct. 08 2021)
Availability of Cisatracurium (Oct. 01 2021)
Safety Update for Anti-thyroid Drugs (Oct. 01 2021)
Hepatitis B Reactivation (Sep. 23 2021)
Availability of Imdur® and Monodur® (Sep. 23 2021)
Discontinuation of Propofol Sandoz® (Sep. 21 2021)
Availability of Daivobet® (Sep. 21 2021)
Packaging Update for Revlimid® and Pomalyst® (Sep. 21 2021)
Cariprazine on the Pharmaceutical Benefits Scheme (Sep. 17 2021)
Availability of Local Anaesthetic Products (Sep. 16 2021)
Availability of Targin® (Sep. 10 2021)
Antimicrobial resistance: The need for stewardship (Sep. 08 2021)
Availability of Local Anaesthetic Products (Sep. 06 2021)
Labelling Change for Potassium Chloride Ampoules (Sep. 06 2021)
Availability of Olimel® N9-840E (Sep. 03 2021)
Alternative Adrenaline Autoinjector (Sep. 03 2021)
Stability of Actemra® Vials (Sep. 02 2021)
Cannabis (Aug. 26 2021)
Discontinuation of Lovan® (Aug. 23 2021)
Post-injection Syndrome (Aug. 20 2021)
Availability of Progynova® (Aug. 16 2021)
Melanoma – An Update in Treatment Strategies (Aug. 13 2021)
Product Safety Information for Dilantin® (Aug. 11 2021)
Drug Recall for Avsartan® (Aug. 11 2021)
Alirocumab on the PBS (Aug. 06 2021)
Drug Recall for Champix® (Aug. 02 2021)
New Labelling Standard (Jul. 30 2021)
Availability of Actemra® (Jul. 28 2021)
Update to Empagliflozin (Jul. 23 2021)
Administration Advice for KabiPac® (Jul. 22 2021)
Availability of Nifedipine (Jul. 21 2021)
Discontinuation of Intal® Forte (Jul. 20 2021)
Prevention of Shingles (Jul. 16 2021)
Appearance Issue for Tofranil® (Jul. 16 2021)
Discontinuation of Ciprofloxacin Alphapharm (Jul. 15 2021)
Discontinuation of Pregnyl® (Jul. 14 2021)
Availability of Folic Acid Vials (Jul. 13 2021)
Availability of Carbosorb® X (Jul. 12 2021)
Availability of Local Anaesthetic Products (Jul. 12 2021)
Availability of Actemra® (Jul. 12 2021)
Expanded PBS criteria for Nivolumab and Ipilimumab (Jul. 09 2021)
Melatonin down scheduling: a brief update (Jul. 01 2021)
Triple Therapy for COPD (Jun. 24 2021)
Product Defect Alert for Recothrom® (Jun. 22 2021)
Topical treatment in psoriasis (Jun. 17 2021)
Availability of Sodium Citrate (Jun. 15 2021)
Availability of Diazepam Rectal Solution (Jun. 15 2021)
Availability of Tranexamic Acid Tablets (Jun. 15 2021)
Progesterone for Prevention of Preterm Birth (Jun. 11 2021)
PBS Change for Fragmin® (Jun. 09 2021)
Discontinuation of Aciclovir Intravenous Infusion (Pfizer) (Jun. 08 2021)
Product Defect Alert for Ospolot® (Jun. 07 2021)
Progress of Cervical Cancer Elimination (Jun. 04 2021)
Availability of Diazepam Rectal Solution (Jun. 03 2021)
Presentation Change for Phenasen® (Jun. 01 2021)
Availability of Nitrofurantoin (May. 30 2021)
Olaparib Indications Extended (May. 28 2021)
Availability of Cernevit® (May. 26 2021)
Recall of Hydralyte® Strawberry Kiwi Effervescent Electrolyte Tablets (May. 25 2021)
Discontinuation of Kaluril® (May. 25 2021)
Availability of Miochol-E® (May. 21 2021)
New Action Plan for Pain Management (May. 21 2021)
Availability of Carbosorb® XS (May. 21 2021)
Packaging Change for AmBisome® (May. 20 2021)
Availability of Progynova® (May. 13 2021)
Cannabidiol for Dravet Syndrome (May. 13 2021)
Availability of Cocaine Products (May. 13 2021)
Availability of Panadol® Suppositories (May. 10 2021)
Discontinuation of Edecrin® (May. 07 2021)
Thyroid Awareness Month (May. 06 2021)
Removal of Baraclude® from the PBS (May. 05 2021)
Presentation Change of Ropivacaine Kabi (May. 04 2021)
Availability of Mucosoothe® Oral Gel (May. 04 2021)
Availability of Local Anaesthetic Products (Apr. 30 2021)
PBS Changes for Adalimumab (Apr. 30 2021)
Availability of Clexane® (Apr. 29 2021)
Availability of Cocaine Products (Apr. 23 2021)
Influenza Vaccines (Apr. 23 2021)
Presentation Change for Morphine Juno (Apr. 16 2021)
Short-course Oxycodone (Apr. 16 2021)
Availability of Aciclovir Eye Ointment (Apr. 15 2021)
Availability of Phenelzine (Apr. 09 2021)
Treatment of Eosinophilic Oesophagitis (Apr. 09 2021)
Availability of Local Anaesthetic Products (Apr. 08 2021)
Presentation of Salbutamol Inhalers (Apr. 06 2021)
Availability of Synacthen® (Apr. 01 2021)
Availability of Ketorolac Ampoules (Apr. 01 2021)
Availability of Fresofol® (Mar. 31 2021)
Ozanimod on the PBS (Mar. 31 2021)
Recall of Histoacryl® (Mar. 30 2021)
Discontinuation of DBL™ Cephalothin (Mar. 30 2021)
Discontinuation of Urocit®-K (Mar. 26 2021)
Availability of Stemetil® Ampoules (Mar. 26 2021)
iAluRil® and Interstitial Cystitis (Mar. 26 2021)
New Dermatitis Therapy on the PBS (Mar. 19 2021)
Discontinuation of Ranitidine (Mar. 15 2021)
Pertuzumab in the neoadjuvant setting; early or locally advanced HER-2 positive breast cancer patients (Mar. 12 2021)
Availability of Nitrostat® (Mar. 10 2021)
Availability of Diasp® (Mar. 05 2021)
New Asthma Therapy Listed on the PBS (Mar. 05 2021)
Discontinuation of MS Contin® Suspension (Mar. 04 2021)
Availability of Intralipid® (Mar. 03 2021)
Discontinuation of DBL™ Papaverine (Mar. 03 2021)
Availability of Urex® Forte (Mar. 02 2021)
Hospital-initiated Medication Reviews (Feb. 26 2021)
Availability of Predsol® Suppositories (Feb. 25 2021)
Availability of Prednefrin® Forte (Feb. 25 2021)
Availability of Famciclovir Tablets (Feb. 25 2021)
Availability of Indometacin Capsules (Feb. 23 2021)
Updated Contraindications for Metronidazole (Feb. 17 2021)
Product Defect Correction for AmBisome® (Feb. 15 2021)
Removal of Mabthera® IV and Tarceva® from the PBS (Feb. 12 2021)
Boxed Warnings for Gabapentinoids (Feb. 10 2021)
New Therapy for Advanced Gastrointestinal Stromal Tumours (Feb. 05 2021)
Discontinuation of Dilaudid® Oral Liquid (Feb. 04 2021)
COVID-19 Vaccines (Jan. 28 2021)
Safety Notice for Minisart® NML / Ophthalsart (Jan. 28 2021)
Apremilast on the PBS (Jan. 22 2021)
Ergometrine maleate injection (500 microgram/mL) ampoule (Jan. 22 2021)
Updates to the Poisons Standard (Jan. 15 2021)
Extended Indications for Dapagliflozin (Jan. 06 2021)
Product Defect Alert for Methotrexate Accord (Dec. 24 2020)
Recall of Tenofovir Disoproxil Emtricitabine Mylan (Dec. 23 2020)
Availability of Sertraline (Dec. 23 2020)
Active Ingredient Prescribing (Dec. 23 2020)
Beclometasone and Formoterol Inhaler (Dec. 23 2020)
Availability of Estradot® (Dec. 22 2020)
Discontinuation of Diacol® (Dec. 21 2020)
New Digital Mental Health Standards (Dec. 18 2020)
Availability of Fibro-Vein™ (Dec. 18 2020)
Discontinuation of DBL™ Irinotecan (Dec. 16 2020)
New PBS Listing for Rivaroxaban (Dec. 11 2020)
Approval of New Prescription Medications (Dec. 04 2020)
Availability of Glyceryl Trinitrate (Dec. 03 2020)
Potential Metformin Contamination (Nov. 27 2020)
Antimicrobial Resistance (Nov. 20 2020)
Availability of Qvar® (Nov. 13 2020)
Siponimod on the PBS (Nov. 13 2020)
2021 HPS Lecture Series Programme (Nov. 10 2020)
Vaccines and Cold Chain (Nov. 06 2020)
Availability of Cytotec® (Nov. 05 2020)
Availability of Teveten® (Nov. 02 2020)
Availability of Eliquis® (Nov. 02 2020)
Product Notice for Milrinone (Nov. 02 2020)
Expanded PBS Listing for Apomorphine (Oct. 30 2020)
Darolutamide (Nubeqa®) in Prostate Cancer (Oct. 22 2020)
Availability of Tranylcypromine (Oct. 20 2020)
Aflibercept on the PBS (Oct. 16 2020)
Availability of DBL™ Leucovorin Calcium (Oct. 15 2020)
Availability of Voltaren® Ophtha (Oct. 14 2020)
Availability of Cilicaine® Syringe (Oct. 13 2020)
Drugs in Sport (Oct. 09 2020)
Availability of Alphagan® P (Oct. 08 2020)
Lorlatinib on the PBS (Oct. 02 2020)
Treatment of Infantile Haemangioma (Sep. 25 2020)
Availability of Urex® Forte (Sep. 25 2020)
Discontinuation of Glucose Intravenous Infusion BP 5% (Sep. 25 2020)
Availability of Panadol® Suppositories (Sep. 25 2020)
Removal of Bufexamac Products (Sep. 18 2020)
Product Notice for Local Anaesthetics (Sep. 18 2020)
Discontinuation of Tinidazole (Sep. 15 2020)
Recall of Pharmacy Action Antiseptic Cream (Sep. 11 2020)
Abemaciclib for Breast Cancer (Sep. 11 2020)
Product Notice for Sinemet® Tablets (Sep. 10 2020)
Acalabrutinib on the PBS (Sep. 04 2020)
Availability of Tambocor® Ampoules (Sep. 01 2020)
Availability of Local Anaesthetic Products (Sep. 01 2020)
Availability of Intranasal Minirin® (Aug. 31 2020)
Availability of Sinemet® CR (Aug. 31 2020)
Primary Cutaneous T-cell Lymphoma (Aug. 28 2020)
Availability of DBL™ Magnesium Sulfate Ampoules (Aug. 24 2020)
Availability of Intal® and Intal Forte® (Aug. 24 2020)
Availability of Captopril (Aug. 24 2020)
Hydrochlorothiazide and Skin Cancer (Aug. 21 2020)
Availability of Chlorhexidine Pre-Op Wash (Aug. 21 2020)
Availability of Phenytoin Ampoules (Aug. 18 2020)
Availability of Suxamethonium (Aug. 18 2020)
Safety Advisory for Oxycodone Sandoz® (Aug. 14 2020)
Availability of Brevinor® and Norimin® (Aug. 14 2020)
Recall of Abstral® (Aug. 12 2020)
Gliflozins and Heart Failure (Aug. 12 2020)
Availability of Clexane® (Aug. 11 2020)
Availability of Healon GV® (Aug. 11 2020)
Zoster vaccine and immunosuppression (Aug. 07 2020)
Discontinuation of Fresofol® LCT (Aug. 03 2020)
Availability of Gastrogel® (Aug. 03 2020)
Availability of Local Anaesthetic Products (Aug. 03 2020)
Remdesivir – an emerging treatment for COVID-19 patients. (Jul. 31 2020)
Availability of Vancomycin Alphapharm (Jul. 27 2020)
Availability of Symbicort® Rapihaler® (Jul. 27 2020)
Semaglutide on the PBS (Jul. 24 2020)
Availability of Zoely® Tablets (Jul. 22 2020)
Availability of Minirin® Nasal Spray (Jul. 22 2020)
Safe Injection Practices (Jul. 17 2020)
Recall of Sodium Chloride Bags (Jul. 10 2020)
Updates to the PBS criteria for evolocumab (Jul. 09 2020)
Diabetes and Insulin (Jul. 02 2020)
Availability of Local Anaesthetic Products (Jul. 01 2020)
Availability of Suxamethonium (Jul. 01 2020)
Recall of Abstral® (Jul. 01 2020)
Discontinuation of Roferon-A® (Jun. 18 2020)
Hydroxychloroquine as triple therapy in COVID-19 patients (Jun. 16 2020)
Combination Inhaler for Mild Asthma (Jun. 10 2020)
Tocilizumab, COVID-19 and the cytokine storm (Jun. 03 2020)
Defect Correction for Tacrolimus Apotex (Jun. 02 2020)
Insulin Glargine on the PBS (May. 27 2020)
Availability of Marevan® (May. 22 2020)
Availability of Fresofol® (May. 21 2020)
Colchicine use in Acute Myocardial Infarction (May. 20 2020)
Discontinuation of Effient® (May. 20 2020)
Availability of Artane® (May. 19 2020)
Availability of Pulmicort® & Symbicort® Turbuhalers® (May. 18 2020)
2020 HPS Lecture Series Programme (May. 15 2020)
Availability of Metformin (May. 14 2020)
PBS Changes for Common Antibiotics (May. 13 2020)
Changes to Opioid PBS Listings (May. 06 2020)
Discontinuation of Isuprel™ (Apr. 29 2020)
Neuraminidase Inhibitors for Influenza (Apr. 29 2020)
Availability of Local Anaesthetic Products (Apr. 28 2020)
Discontinuation of Asasantin® SR and Persantin® SR (Apr. 22 2020)
Availability of Metronidazole (Apr. 22 2020)
Coronavirus Disease (Apr. 22 2020)
Availability of Cisatracurium (Apr. 20 2020)
Availability of Aminophylline Ampoules (Apr. 17 2020)
Availability of Dobutamine Injection (Apr. 17 2020)
National COVID-19 Guidelines (Apr. 16 2020)
Risk of Viral Transmission with Nebulised Medication Delivery (Apr. 09 2020)
Availability of Levothyroxine (Apr. 09 2020)
Availability of Suxamethonium Ampoules (Apr. 09 2020)
Availability of Ipratropium Nebules (Apr. 07 2020)
Availability of Aminophylline Ampoules (Apr. 07 2020)
Discontinuation of Nardil® (Apr. 06 2020)
Availability of Gentamicin (Apr. 02 2020)
Prescribing Restrictions for Hydroxychloroquine (Apr. 02 2020)
Availability of Local Anaesthetic Products (Apr. 01 2020)
COVID-19 Summary of Published Information (Mar. 26 2020)
Availability of Adrenaline (Epinephrine) (Mar. 25 2020)
Defect correction for Palexia® SR 100mg (Mar. 24 2020)
Update on Influenza Vaccines (Mar. 19 2020)
Availability of Quinapril (Mar. 18 2020)
Availability of Firmagon® (Mar. 16 2020)
New PBS-listing for Atezolizumab in treatment of extensive-stage small cell lung cancer (Mar. 12 2020)
Availability of Lubricating Eye Ointments (Mar. 06 2020)
Generic Tiotropium Capsules (Mar. 05 2020)
Availability of Antabuse® (Mar. 05 2020)
Availability of Nifedipine (Mar. 04 2020)
Availability of Hydrocortisone Tablets (Mar. 03 2020)
Availability of Tilade® (Mar. 03 2020)
Availability of Local Anaesthetic Products (Mar. 02 2020)
Xerostomia (Feb. 27 2020)
Availability of Glucose Intravenous Infusion (Feb. 26 2020)
Availability of Ephedrine Hydrochloride (Feb. 26 2020)
Availability of OsmoLax® (Feb. 26 2020)
Availability of Famotidine (Feb. 26 2020)
Availability of BenPen™ (Feb. 21 2020)
Availability of Carbimazole (Feb. 21 2020)
Availability of Calcium Gluconate Gel (Feb. 21 2020)
Availability of Pindolol (Feb. 21 2020)
Availability of Bleomycin Vials (Feb. 21 2020)
Non-Steroidal Topical Therapy for Dermatitis (Feb. 20 2020)
Availability of Prazosin (Feb. 20 2020)
Availability of Phenoxymethylpenicillin (Feb. 20 2020)
Availability of Dantrolene (Feb. 20 2020)
Availability of Minipress® (Feb. 20 2020)
Availability of Verapamil Tablets (Feb. 19 2020)
Availability of Carafate® Tablets (Feb. 19 2020)
Availability of Pneumovax® 23 (Feb. 18 2020)
Availability of Span-K® Tablets (Feb. 17 2020)
Availability of Irinotecan (Feb. 17 2020)
Defect correction for Palexia® SR 100mg (Feb. 14 2020)
Availability of Haemorol™ (Feb. 14 2020)
Availability of Primacin® (Feb. 14 2020)
Availability of EpiPen® Jr. (Feb. 14 2020)
Monoclonal Antibodies for Migraine (Feb. 13 2020)
Availability of Amoxicillin & Clavulanic Acid Suspension (Feb. 12 2020)
Availability of Emollient Ointment Sterile (Feb. 11 2020)
Availability of Hydroxocobalamin Ampoules (Feb. 11 2020)
Availability of Fleet® Ready-to-Use Enema (Feb. 07 2020)
Availability of Gentamicin Ampoules (Feb. 07 2020)
Availability of Hand Sanitisers (Feb. 07 2020)
Availability of Ciprofloxacin IV (Feb. 07 2020)
Updated PBS-listing for Pembrolizumab in treatment of metastatic non-small cell lung cancer (Feb. 07 2020)
Availability of Zyban® SR Tablets (Feb. 06 2020)
Availability of DBL™ Rocuronium Bromide Vials (Feb. 05 2020)
Availability of Gastrogel Antacid® Oral Suspension (Feb. 05 2020)
Availability of Integrilin® (Feb. 05 2020)
Availability of Tamoxifen Tablets (Feb. 04 2020)
Availability of Ferro-Grad C® Tablets (Feb. 04 2020)
Availability of Minims® Phenylephrine Eye Drops (Feb. 04 2020)
Availability of Panadol® Suppositories (Feb. 04 2020)
Discontinuation of Zantac® Effervescent (Feb. 03 2020)
Availability of Nitrostat® Tablets (Jan. 31 2020)
Availability of Isoprenaline Ampoules (Jan. 30 2020)
Appearance Change for Temazepam Tablets (Jan. 30 2020)
Changes to Neural Connector Devices (Jan. 30 2020)
Availability of Pethidine (Jan. 24 2020)
Updated Oral and Dental Guidelines (Jan. 24 2020)
Availability of Minims® Phenylephrine Eye Drops (Jan. 23 2020)
Venetoclax (Jan. 16 2020)
New Contraindications for Glaucoma Medication (Jan. 10 2020)
Biosimilars in Oncology (Jan. 03 2020)
Ceftazidime with Avibactam (Dec. 27 2019)
Availability of Sodium Bicarbonate Vials (Dec. 20 2019)
Availability of Local Anaesthetic Products (Dec. 20 2019)
Availability of Hyalase® (Dec. 20 2019)
Availability of Phenelzine (Dec. 20 2019)
Availability of Famotidine (Dec. 19 2019)
Encorafenib, Binimetinib and Cetuximab Triplet Therapy in BRAF V600E- Mutant Metastatic Colorectal Cancer (Dec. 17 2019)
Notice For EpiPen® Jr. (Dec. 17 2019)
Teduglutide for Short Bowel Syndrome (Dec. 13 2019)
Availability of Kenacort®-A 40 (Dec. 10 2019)
The Role of Somatostatin Analogues in the Management of Gastroenteropancreatic Neuroendocrine Tumours (Dec. 06 2019)
Availability Of Heparin (Dec. 04 2019)
Availability of Local Anaesthetic Products (Dec. 02 2019)
Neratinib for Breast Cancer (Nov. 29 2019)
Availability of Marcain with Fentanyl (Nov. 22 2019)
Prescription Opioid Changes (Nov. 22 2019)
Availability Of Nizatidine Capsules (Nov. 15 2019)
Antibiotic Awareness Week (Nov. 15 2019)
Availability of Nizatidine Capsules (Nov. 14 2019)
Diabetes Medications in the Peri-Operative Period (Nov. 08 2019)
Buprenorphine Depot Injections (Nov. 01 2019)
Availability of Cyclizine Ampoules (Oct. 31 2019)
Product Notice for Clexane® Syringes (Oct. 29 2019)
Availability of Cefalotin (Oct. 29 2019)
Availability of Gentamicin (Oct. 28 2019)
Availability of Docetaxel (Oct. 25 2019)
Availability of Tranylcypromine (Oct. 25 2019)
Availability of Cefalotin (Oct. 25 2019)
Lamotrigine Dose Escalation (Oct. 25 2019)
Availability of Kenacort®-A 40 (Oct. 24 2019)
New Warning for Febuxostat (Oct. 18 2019)
Availability of OncoTICE® (Oct. 16 2019)
Wilson Disease (Oct. 11 2019)
Availability of Tranylcypromine (Oct. 11 2019)
Discontinuation of Morphine Tartrate (Oct. 11 2019)
Availability of Azithromycin Vials (Oct. 07 2019)
Recall of Ranitidine Products (Oct. 07 2019)
Naloxone Nasal Spray (Oct. 04 2019)
Availability of Heparin Sodium (Oct. 03 2019)
Zantac® Products (Oct. 02 2019)
Ranitidine Products (Oct. 02 2019)
Parkinson’s Disease and Hospitalisation (Sep. 27 2019)
Availability of Local Anaesthetic Products (Sep. 23 2019)
Product Notice for Metaraminol Juno Syringes (Sep. 23 2019)
Ranitidine Products (Sep. 23 2019)
Anticoagulants in Antiphospholipid Syndrome (Sep. 20 2019)
Product Notice for Metaraminol Juno Pre-Filled Syringes (Sep. 19 2019)
Safety Alert for Ranitidine (Sep. 18 2019)
Availability of Span-K® Tablets (Sep. 17 2019)
Understanding Clinical Trials (Sep. 13 2019)
Local Anaesthetics for Oromucosal Use (Sep. 06 2019)
Availability of Midazolam (Sep. 03 2019)
Availability of Adrenaline (Sep. 03 2019)
Availability of Sodium Citrate Dihydrate (Sep. 03 2019)
Availability of Tranylcypromine (Aug. 30 2019)
Availability of Sulfamethoxazole + Trimethoprim Ampoules (Aug. 30 2019)
Short-Course Oxycodone Packs (Aug. 30 2019)
Availability of Morphine Tartrate (Aug. 27 2019)
Availability of Local Anaesthetic Products (Aug. 26 2019)
Rufinamide for Lennox-Gastaut Syndrome (Aug. 23 2019)
Availability of Heparin (Aug. 19 2019)
Tafenoquine: A Novel Anti-Malarial (Aug. 16 2019)
Discontinuation of Timoptol-XE® 0.25% (Aug. 14 2019)
New Treatment for Carcinoid Syndrome (Aug. 09 2019)
Quarantine Update for Baxter Infusion Bags (Aug. 06 2019)
Product Notice for Juno Pre-Filled Syringes (Aug. 06 2019)
Discontinuation of Pfizer Antibiotics (Aug. 06 2019)
Medicinal Marijuana? (Aug. 02 2019)
Availability of BenPen (Aug. 01 2019)
Availability of Nicorandil (Aug. 01 2019)
Availability of Local Anaesthetic Products (Aug. 01 2019)
Product Defect Correction for Endone® (Jul. 31 2019)
Quarantine for Endone® (Jul. 29 2019)
PBS Changes for Pembrolizumab Listing (Jul. 26 2019)
Availability of Ventolin® Syrup (Jul. 24 2019)
Discontinuation of Gelclair® Oral Gel (Jul. 24 2019)
Primary Prevention: a Low-Dose Aspirin Story (Jul. 19 2019)
Discontinuation of Calsource® Ca1000 (Jul. 16 2019)
Discontinuation of Saizen® 3mg (Jul. 16 2019)
Availability of Azithromycin (Jul. 16 2019)
Baxter Potassium Chloride Intravenous Infusion Bag (Jul. 15 2019)
Updated Results for Pembrolizumab in treatment of metastatic non-small cell lung cancer (Jul. 12 2019)
Hand-Foot Syndrome (Jul. 08 2019)
Availability of Folinic Acid Vials (Jul. 03 2019)
Discontinuation of Keytruda® 50mg (Jul. 03 2019)
Availability of OncoTICE® (Jul. 03 2019)
Availability of Miochol-E (Jul. 02 2019)
Availability of Pethidine (Jul. 02 2019)
Palbociclib added to the Pharmaceutical Benefits Scheme (Jun. 28 2019)
Low Dose Methotrexate for Rheumatoid Arthritis (Jun. 21 2019)
Availability of Heparin (Jun. 19 2019)
Availability of Local Anaesthetic Products (Jun. 19 2019)
Availability of Fentanyl Ampoules (Jun. 17 2019)
Faster-Acting Insulin Aspart (Jun. 14 2019)
Availability of Local Anaesthetic Products (Jun. 13 2019)
Introduction to the storage of medications in a private hospital setting (Jun. 07 2019)
Availability of Zyban® SR (Jun. 06 2019)
Availability of Heparin (Jun. 05 2019)
Availability of Local Anaesthetic Products (Jun. 03 2019)
Availability of Septrin® Oral Liquid (May. 31 2019)
Packaging Update for Laceraine® (May. 31 2019)
Alemtuzumab Safety Review (May. 31 2019)
Safety Alert for Adrenaline (May. 30 2019)
Availability of Ventolin® Ampoules (May. 24 2019)
Lactulose for Hepatic Encephalopathy (May. 24 2019)
Recall for Curam Duo (May. 22 2019)
Availability of Pemetrexed (May. 17 2019)
Safinamide for Parkinson’s Disease (May. 17 2019)
Availability of Irbesartan (May. 16 2019)
Availability of Flucloxacillin (May. 16 2019)
Availability of Metoclopramide Ampoules (May. 14 2019)
Proton Pump Inhibitor Restrictions (May. 10 2019)
Availability of Priorix® and Priorix-Tetra® (May. 09 2019)
Availability of Fentanyl Ampoules (May. 09 2019)
Availability of Minims® Eye Drops (May. 09 2019)
Updated Recommendations for Measles Vaccination (May. 03 2019)
Availability of Fentanyl Ampoules (Apr. 26 2019)
Prevention of Recurrent Clostridium difficile Infection (Apr. 25 2019)
Product Recall for Myxazole® (Apr. 24 2019)
Availability of Bleomycin Vials (Apr. 23 2019)
Availability of Local Anaesthetic Products (Apr. 23 2019)
New High-Strength Insulin (Apr. 18 2019)
Availability of Oxycodone Ampoules (Apr. 16 2019)
Updates to the Australian Asthma Handbook (Apr. 12 2019)
Availability of Azithromycin Vial (Apr. 11 2019)
Tofacitinib Safety Issue (Apr. 05 2019)
Availability of Local Anaesthetic Products (Mar. 29 2019)
Availability of Somac Granules (Mar. 29 2019)
Heparins (Mar. 29 2019)
New Medication for Weight Management (Mar. 22 2019)
Safety and Quality Standards for Mental Health (Mar. 15 2019)
Packaging Change for Bicillin L-A (Mar. 08 2019)
Carbimazole Safety Issues (Mar. 08 2019)
Availability of Local Anaesthetic Products (Mar. 04 2019)
Potentially Harmful Medication Use in the Elderly (Mar. 01 2019)
Updated Recall Procedures (Feb. 22 2019)
Availability of Dicloxacillin (Feb. 21 2019)
Animal-Assisted Therapy for Dementia (Feb. 15 2019)
Product Defect Correction for Jurnista® (Feb. 14 2019)
Appropriate Use of Promethazine (Feb. 08 2019)
Availability of Sulfamethoxazole + Trimethoprim (Feb. 04 2019)
Availability of Local Anaesthetic Products (Feb. 01 2019)
Augmented Renal Clearance (Feb. 01 2019)
Recall for Empovir® Vials (Jan. 30 2019)
New Contraindication for Doxycycline (Jan. 25 2019)
Discontinuation of Emend® Capsules (Jan. 24 2019)
Availability of Chlorvescent® Tablets (Jan. 24 2019)
Availability of Citracal Tablets (Jan. 18 2019)
Biofilms (Jan. 18 2019)
Availability of Pantoprazole Vials (Jan. 11 2019)
Ertugliflozin for Type 2 Diabetes (Jan. 11 2019)
Medications and Sun Exposure (Jan. 04 2019)
Availability of Sinemet CR® (Jan. 02 2019)
Recall for Milrinone (Jan. 02 2019)
Pholcodine and Anaphylaxis (Dec. 14 2018)
